Side-by-side IPO readiness, funding history, and valuation comparison. Data sourced by TechStackIPO.
Scores, valuations, and signals for Gimet Labs, Glean, and 370+ companies. 5-min read every Tuesday.
Applied AI research lab translating frontier AI capabilities into production-ready enterprise products.
| Industry | AI Research |
| Stage | Series G |
| IPO Status | Private |
| Valuation | $45.0B |
| Total Funding | $2.65B |
| Headquarters | San Francisco, CA |
Enterprise AI search and knowledge-management platform — autonomous research agents across the company's apps and data.
| Industry | AI / Enterprise Search & Knowledge |
| Stage | Series G |
| IPO Status | Pre-IPO |
| Valuation | $12.0B |
| Total Funding | $600M |
| Headquarters | Palo Alto, CA |
Complete funding history, cap table, S-1 analysis, and investor breakdown for any company. Instant PDF download.
Or buy any single company report for $19
Gimet Labs is valued at $45.0B. Glean is valued at $12.0B. Both figures are based on the most recent funding rounds tracked by TechStackIPO.
Gimet Labs is currently private. Glean is currently pre-IPO. Track both companies on TechStackIPO for S-1 filings, roadshow announcements, and IPO date updates.
Gimet Labs has raised $2.65B. Glean has raised $600M.
Gimet Labs operates in AI Research, while Glean operates in AI / Enterprise Search & Knowledge.
Gimet Labs is a AI Research company valued at $45.0B with $2.65B raised. Glean is a AI / Enterprise Search & Knowledge company valued at $12.0B with $600M raised. See TechStackIPO's full side-by-side comparison for IPO readiness scores, funding timelines, and investor access options.
Accredited investors can access pre-IPO shares in Gimet Labs and Glean through secondary market platforms, pre-IPO funds, and broker-dealer platforms that facilitate private company transactions. TechStackIPO's marketplace section tracks available access options for both companies. Pre-IPO investments carry higher risk and limited liquidity.